Medicinal product name Flixotide 250 micrograms/dose pressurised inhalation, suspension
Pharmaceutical form Pressurised inhalation, suspension
Strength 250 µg/dose 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
02-0135-01 KZSN60 Is available
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
Package leafletMS Word document 22-07-2021
Summary of product characteristicsMS Word document 22-07-2021
ATC code R03BA05 Drugs for obstructive airway diseases

Medicinal products (2)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(265 containers)
Tamro, Recipe Plus, Magnum Medical, Jelgavfarm, Oribalt Rīga N60
(250 µg/1 dose)
  23.53 
KZS*
02-0135-01 Labelling text Labelling text Jul 22, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N120
(250 µg/1 dose)
     02-0135-02 Labelling text Labelling text Jul 22, 2021
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 02-0135
Date of authorisation Jun 10, 2002
Marketing authorisation holder, country GlaxoSmithKline Trading Services Limited, Ireland